'Cns effects' diaporamas de présentation

Pediatric Toxicology

Pediatric Toxicology. M Waseem, MD Lincoln Hospital Bronx New York. Epidemiology. 2 million calls 52% of poison center calls < 6years Peak age 18 months - 3 years. Epidemiology. Unintentional (1-2 years) Exploratory Boys > girls Intentional (adolescent) Purposeful Girls > boys.

1.95k views • 175 slides

Peri o perative Hypertension When Does it Matter?!

Peri o perative Hypertension When Does it Matter?!. Sukh Brar MD FRCPC Royal Columbian Hospital October 26 th , 2013. 1. Definitions 2. Prevalence 3. Pathophysiology 4. Preoperative 5. Intraoperative 6. Postoperative 7. Treatment 8. Outcomes 9. Summary. Objectives.

1.16k views • 104 slides

THERAPEUTIC HYPOTHERMIA AFTER CARDIAC ARREST

THERAPEUTIC HYPOTHERMIA AFTER CARDIAC ARREST. Adam Oster R3 Resident Oral Presentation November 13, 2003. Therapeutic Hypothermia Post Cardiac Arrest. Guiding questions Supporting science Preliminary studies Clinical trials Cooling technology Who to cool When to cool How long to cool.

1.01k views • 66 slides

Chemical (and other) stress in DEB 1: Introduction

Chemical (and other) stress in DEB 1: Introduction. Tjalling Jager Dept. Theoretical Biology. Lectures on (eco)toxicity. Introduction toxic stress is important (and interesting) logical link to DEB theory brief history of toxic stress in DEB Toxicokinetics

706 views • 58 slides

Stage 1 Seminar: Clinical Pharmacology of the Nervous System

1.81k views • 38 slides

ANESTHETICS

595 views • 36 slides

AUTONOMICS

AUTONOMICS. MA. JANETTH B. SERRANO, M.D. DPBA. SYMPATHETIC DRUGS. Site and Mode of Action: 1. Direct Acting Epinephrine - Dobutamine Phenylephrine - Norepinephrine Isoproterenol - Clonidine 2. Indirect Acting Tyramine, Amphetamine, Cocaine 3. Mixed Acting Agonists

461 views • 29 slides

Preclinical Challenges for Assessing Abuse Potential of Nontraditional Drugs and Drug Formulations

Preclinical Challenges for Assessing Abuse Potential of Nontraditional Drugs and Drug Formulations. Nancy A. Ator Division of Behavioral Biology Department of Psychiatry and Behavioral Sciences Johns Hopkins School of Medicine.

367 views • 27 slides

An Introduction To The Health Effects of Solvents

397 views • 23 slides

Sedative-Hypnotics

Teresita N. Avendano-Batanes, M.D., DPBA Department of Anesthesiology College of Mediciane UERMMMCI. Sedative-Hypnotics. Sedative - Hypnotics. Sedative Anxiolytic exerts a calming effect makes one less responsive to stimulation with decreased spontaneous activity Hypnotic

878 views • 23 slides

Caffeine

Caffeine. Drugs and Our Society CJUS/HPE 151 Part 15. Popularity. Most frequently used stimulant - most popular - foods / beverages consumed - average daily intake: 2 cups coffee (200 mg) - 30%: 500 mgs or more daily a. Most common sources:

258 views • 21 slides

CNS Drugs

666 views • 20 slides

Ch. 11 anticholinergic drugs

1.12k views • 15 slides

Chapter 39

Chapter 39. Drug Abuse III: Nicotine and Smoking. Basic Pharmacology of Nicotine. Mechanism of action Pharmacokinetics Pharmacologic effects. Nicotine and Smoking. Main source: tobacco Nicotine is the most dangerous compound in cigarettes

279 views • 7 slides

Parasympathetic agonist & antagonist

Parasympathetic agonist & antagonist. Muscarinic agonist cholinomimetics agents Parasympatho mimetic agents Same effect of Parasympathic system. Muscarinic antagonist or Antimuscarinic drug Parasympatho letic agents Same effect sympathic system. examples:

248 views • 2 slides